Apheresis Market - Global Industry Insights, Trends, Size, Share, Outlook, and Opportunity Analysis, 2018-2026

Seattle, WA -- (SBWire) -- 11/14/2019 --Apheresis Market – Insights

A procedure of blood purification and blood component separation is called apheresis. The procedure is performed for blood donation component or for the treatment of various diseases such as neurological, cardiovascular, renal, autoimmune, hematological and other diseases, using centrifugation or membrane filtration technology. The blood is extracted from the patient or from the donor's body using apheresis machine and required blood components are separated on the basis of their molecular size and weight. The remnant blood is transferred back to the donor's or patient's body.

Get PDF Brochure for Research Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/517

Centrifugation and membrane filtration devices are used in apheresis procedure. The centrifuge therapeutic apheresis device is used to separate plasma or blood components from the whole blood. Centrifugation and membrane filtration devices are automated continuous-flow systems and are used to perform therapeutic plasma exchange, to remove plasma components or fluids, and to perform red blood cells exchange.

Plasma (plasmapheresis), platelets (plateletpheresis), and leukocytes (leukapheresis) are procedures performed in apheresis, among which plateletpheresis is the most widely performed procedure for supplying human leukocyte antigen (HLA) platelets to patient who have become HLA sensitized. The plasma can be removed in plasmapheresis procedure to supply blood components such as RBCs, WBCs, and platelets. Leukapheresis is performed to obtain the patient's own blood cells for later transplant to use in chemotherapy treatments and in the procedure, WBCs are either separated or decreased from the blood sample of the patient for the blood cell count.

Apheresis Market – Taxonomy

By Procedure:
- Erythrocytapheresis
- Leukapheresis
- Plasmapheresis
- Erythrocytapheresis
- Photopheresis
- LDL-apheresis
By Technology:
- Membrane Filtration
- Centrifugation
By Application:
- Cancer
- Autoimmune disease
- Cardiovascular disease
- Renal diseases
- Neurology
- Hematology
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa

Request For Customization at: https://www.coherentmarketinsights.com/insight/request-customization/517

Apheresis Market: Drivers

Increasing prevalence of chronic diseases such as cancer and high rate of blood donation is expected to boost growth of the apheresis market. For instance, according to the World Health Organization (WHO), around 14 million new cases of cancer were reported in 2012. Plasma therapeutic products such as immunoglobulin, albumin, platelets, and plasma are widely used for the treatment of cancer. Moreover, according to the WHO, in 2013, 112.5 million blood donations were collected globally and around half of these were collected in the developed countries such as the U.S. and Canada. Furthermore, the blood donation rate was around 35.0 per 1000 population in developed countries such as the U.S. and 11.7 per 1000 population in middle-income countries such as India and 4.6 per 1000 population in low-income countries such as Afghanistan. Also, the blood donations rate increased by 10.7 million in between 2008 to 2013.

Apheresis Market: Regional Analysis

On the basis of region, the global apheresis market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. The market in North America is expected account for major market share, owing to increasing prevalence of chronic disorders in the region. For instance, according to Centers for Disease Control and Prevention (CDC), in 2012, around 117 million adults were suffering from one or more chronic conditions. Furthermore, in the U.S., out of all adult population, 1 of 4 adult had 2 or more chronic health conditions.
The market in Asia Pacific is primarily driven by high adoption of therapeutic apheresis procedures and increasing prevalence of chronic disorders.

Apheresis Market: Competitive Landscape

Major players operating in the global apheresis market include, Cerus Corporation, B. Braun, Melsungen AG, HemaCare Corporation, Haemonetics Corporation, Fresenius Kabi AG, Kawasumi Laboratories Inc., NIKKISO CO. LTD., Asahi Kasei Medical Co. Ltd., Therakos, Inc., and Medica S.p.A.

For More Details On this Report: https://www.coherentmarketinsights.com/ongoing-insight/apheresis-market-517